GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
GenMark Diagnostics stock has really not made any of the zany exponential gains that have been seen in other coronavirus-related stocks.
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.
It seems that analysts are taking the forefront and making calls on where the biopharma industry is going ahead of action by the Trump administration.
Some investors are also now starting to look beyond traditional Dow and S&P 500 stocks for value and upside, particularly if there is a mix of growth and value that is not as widely known.
We have an unusual cast of characters in this week’s version of THE UNUSUAL SUSPECTS for the week ahead, with almost none being tied to earnings.  Some of the key stocks to watch with events ahead...